Global Access Diagnostics (GADx) and BBI Solutions Announce Strategic Collaboration to Accelerate Rapid Lateral Flow Product Development and Manufacturing for Commercial Customers
10 October 2025 – Bedfordshire, UK & Crumlin, Wales, UK – Global Access Diagnostics (GADx), a leading innovator in the design and development of in vitro diagnostic and lateral flow products and reagents, has today announced a strategic collaboration with BBI Solutions, a global expert in reagent development and scaled immuno-diagnostic product manufacturing. This partnership brings together two industry leaders to offer end-to-end solutions for commercial clients, significantly reducing time-to-market while enhancing quality, scale, and regulatory assurance.
The collaboration is designed to meet the evolving needs of the global diagnostics market by combining GADx’s deep scientific and regulatory expertise with BBI Solutions’ world-class manufacturing infrastructure. Together, the companies offer a seamless, scalable pathway from concept to commercialisation, delivering unrivalled value to customers seeking speed, flexibility, and technical excellence across human, veterinary, and agricultural immuno-diagnostic development.
Key benefits for customers include:
- End-to-End Expertise: GADx’s comprehensive capabilities in assay design, product development, and clinical validation are fully integrated with BBI’s robust scale-up and manufacturing services, enabling a smooth transition from R&D to market launch.
- Seamless Technology Transfer: The collaboration ensures exemplar technology transfer, enabling rapid scale-up and reducing product development timelines—essential for competitive market entry.
- Enhanced Manufacturing Capacity: With BBI’s international footprint and scalable production systems, clients gain access to increased capacity for both reagents and finished products.
- De-Risked Supply Chain: BBI’s specialist reagent development and incorporation into final products reduces the risk of supply chain disruptions and ensures consistent product performance.
- Regulatory and Clinical Excellence: GADx’s proven regulatory and clinical services streamline global market access, supporting CE, UKCA, and FDA submissions with a flexible, client-centred approach.
- Agile and Collaborative Service Model: Clients benefit from a collaborative partnership structure tailored to individual project needs, from early feasibility to post-market support.
Dr. Mark Street-Docherty, Chief Executive Officer at GADx, commented:
“This collaboration unlocks tremendous value for our partners by aligning scientific innovation with high-quality, scalable manufacturing. Together with BBI Solutions, we can offer a truly integrated and flexible solution that meets the rigorous demands of today’s market.”
Alexander A. Socarrás, Group CEO at BBI Solutions, added:
“Combining our manufacturing strength with GADx’s exceptional development and regulatory expertise allows us to support customers more comprehensively than ever before. This partnership reflects our shared commitment to quality, speed, and customer success.”
The GADx–BBI Solutions partnership marks a significant step forward in delivering next-generation diagnostic solutions to global markets faster, more reliably, and with expert guidance at every stage.
About Global Access Diagnostics (GADx):
GADx (formerly Mologic Ltd) is a mission-led organisation that combines scientific excellence with global health impact. With deep expertise in human, veterinary and agricultural lateral flow and rapid diagnostics design and development. GADx provides end-to-end product development, technology transfer, regulatory services, and clinical evaluation tailored to commercial and global health partners.
About BBI Solutions:
BBI Solutions is a trusted global provider of high-quality reagents and IVD manufacturing services. With decades of experience supporting diagnostic developers and manufacturers, BBI’s facilities are ISO 13485 certified and designed to deliver scale, consistency, and technical excellence across product lifecycles.
For media inquiries, please contact:
GADx Media Relations
Email: info@globalaccessdx.com
Phone: +44 (0)1234 780020
BBI Solutions Communications
Email: info@bbisolutions.com
Phone: +44 (0)1495 363000
© 2025 Global Access Diagnostics and BBI Solutions. All rights reserved.